Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies

Introduction: Duchenne (DMD) and Becker (BMD) muscular dystrophy are X-linked muscular disorders produced by mutations in the DMD gene which encodes the protein dystrophin. Both diseases are characterized by progressive involvement of skeletal, cardiac, and respiratory muscles. As new treatment stra...

ver descrição completa

Detalhes bibliográficos
Autores: Alonso-Jiménez, Alicia|||0000-0002-2200-9255, Fernández Simón, Esther|||0000-0003-4804-6553, Natera-de Benito, Daniel|||0000-0001-7764-2085, Ortez González, Carlos Ignacio|||0000-0001-8187-8103, García, Carme, Montiel Morillo, Elena, Belmonte Jimeno, Izaskun|||0000-0003-0930-6586, Pedrosa Hernández, Irene, Segovia, Sonia, Piñol-Jurado, Patricia|||0000-0002-2757-5758, Carrasco-Rozas, Ana|||0000-0003-2165-8162, Suarez-Calvet, Xavier|||0000-0002-5314-6607, Jiménez Mallebrera, Cecilia|||0000-0001-8203-7103, Nascimento, Andrés, Llauger, Jaume|||0000-0002-3744-3257, Nuñez Peralta, Claudia Alejandra|||0000-0002-3235-0799, Montesinos, Paula|||0000-0001-6944-7730, Alonso Pérez, Jorge|||0000-0001-8866-5186, Gallardo, Eduard|||0000-0002-3942-3436, Illa, Isabel|||0000-0002-2186-2684, Diaz-Manera, Jordi|||0000-0003-2941-7988
Tipo de documento: artigo
Data de publicação:2021
País:España
Recursos:Universitat Autònoma de Barcelona
Repositório:Dipòsit Digital de Documents de la UAB
Idioma:inglês
OAI Identifier:oai:ddd.uab.cat:256414
Acesso em linha:https://ddd.uab.cat/record/256414
https://dx.doi.org/urn:doi:10.3389/fneur.2021.659922
Access Level:Acceso aberto
Palavra-chave:PDGF
MRI
Biomarker
Duchenne
Becker
Dystrophinopathy
id ES_ce7e7ea94708db3dbdc65e99aad8bf32
oai_identifier_str oai:ddd.uab.cat:256414
network_acronym_str ES
network_name_str España
repository_id_str
spelling Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in DystrophinopathiesAlonso-Jiménez, Alicia|||0000-0002-2200-9255Fernández Simón, Esther|||0000-0003-4804-6553Natera-de Benito, Daniel|||0000-0001-7764-2085Ortez González, Carlos Ignacio|||0000-0001-8187-8103García, CarmeMontiel Morillo, ElenaBelmonte Jimeno, Izaskun|||0000-0003-0930-6586Pedrosa Hernández, IreneSegovia, SoniaPiñol-Jurado, Patricia|||0000-0002-2757-5758Carrasco-Rozas, Ana|||0000-0003-2165-8162Suarez-Calvet, Xavier|||0000-0002-5314-6607Jiménez Mallebrera, Cecilia|||0000-0001-8203-7103Nascimento, AndrésLlauger, Jaume|||0000-0002-3744-3257Nuñez Peralta, Claudia Alejandra|||0000-0002-3235-0799Montesinos, Paula|||0000-0001-6944-7730Alonso Pérez, Jorge|||0000-0001-8866-5186Gallardo, Eduard|||0000-0002-3942-3436Illa, Isabel|||0000-0002-2186-2684Diaz-Manera, Jordi|||0000-0003-2941-7988PDGFMRIBiomarkerDuchenneBeckerDystrophinopathyIntroduction: Duchenne (DMD) and Becker (BMD) muscular dystrophy are X-linked muscular disorders produced by mutations in the DMD gene which encodes the protein dystrophin. Both diseases are characterized by progressive involvement of skeletal, cardiac, and respiratory muscles. As new treatment strategies become available, reliable biomarkers and outcome measures that can monitor disease progression are needed for clinical trials. Methods: We collected clinical and functional data and blood samples from 19 DMD patients, 13 BMD patients, and 66 healthy controls (8 pediatric and 58 adult controls), and blood samples from 15 patients with dysferlinopathy (DYSF) and studied the serum concentration of 4 growth factors involved in the process of muscle fibrosis. We correlated the serum concentration of these growth factors with several muscle function tests, spirometry results and fat fraction identified by quantitative Dixon muscle MRI. Results: We found significant differences in the serum concentration of Platelet Derived Growth Factor-AA (PDGF-AA) between DMD patients and pediatric controls, in Connective Tissue Growth Factor (CTGF) between BMD patients and adult controls, and in and Transforming Growth Factor- β1 (TGF-β1) between BMD and DYSF patients. PDGF-AA showed a good correlation with several muscle function tests for both DMD and BMD patients and with thigh fat fraction in BMD patients. Moreover, PDGF-AA levels were increased in muscle biopsies of patients with DMD and BMD as was demonstrated by immunohistochemistry and Real-Time PCR studies. Conclusion: Our study suggests that PDGF-AA should be further investigated in a larger cohort of DMD and BMD patients because it might be a good biomarker candidate to monitor the progression of these diseases. 22021-01-0120212021-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/256414https://dx.doi.org/urn:doi:10.3389/fneur.2021.659922reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengMinisterio de Economía y Competitividad https://doi.org/10.13039/501100003329 PI15/01822Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI18/1525Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI19/00122Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 CD18/00195open accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2564142026-06-06T12:50:31Z
dc.title.none.fl_str_mv Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies
title Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies
spellingShingle Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies
Alonso-Jiménez, Alicia|||0000-0002-2200-9255
PDGF
MRI
Biomarker
Duchenne
Becker
Dystrophinopathy
title_short Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies
title_full Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies
title_fullStr Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies
title_full_unstemmed Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies
title_sort Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies
dc.creator.none.fl_str_mv Alonso-Jiménez, Alicia|||0000-0002-2200-9255
Fernández Simón, Esther|||0000-0003-4804-6553
Natera-de Benito, Daniel|||0000-0001-7764-2085
Ortez González, Carlos Ignacio|||0000-0001-8187-8103
García, Carme
Montiel Morillo, Elena
Belmonte Jimeno, Izaskun|||0000-0003-0930-6586
Pedrosa Hernández, Irene
Segovia, Sonia
Piñol-Jurado, Patricia|||0000-0002-2757-5758
Carrasco-Rozas, Ana|||0000-0003-2165-8162
Suarez-Calvet, Xavier|||0000-0002-5314-6607
Jiménez Mallebrera, Cecilia|||0000-0001-8203-7103
Nascimento, Andrés
Llauger, Jaume|||0000-0002-3744-3257
Nuñez Peralta, Claudia Alejandra|||0000-0002-3235-0799
Montesinos, Paula|||0000-0001-6944-7730
Alonso Pérez, Jorge|||0000-0001-8866-5186
Gallardo, Eduard|||0000-0002-3942-3436
Illa, Isabel|||0000-0002-2186-2684
Diaz-Manera, Jordi|||0000-0003-2941-7988
author Alonso-Jiménez, Alicia|||0000-0002-2200-9255
author_facet Alonso-Jiménez, Alicia|||0000-0002-2200-9255
Fernández Simón, Esther|||0000-0003-4804-6553
Natera-de Benito, Daniel|||0000-0001-7764-2085
Ortez González, Carlos Ignacio|||0000-0001-8187-8103
García, Carme
Montiel Morillo, Elena
Belmonte Jimeno, Izaskun|||0000-0003-0930-6586
Pedrosa Hernández, Irene
Segovia, Sonia
Piñol-Jurado, Patricia|||0000-0002-2757-5758
Carrasco-Rozas, Ana|||0000-0003-2165-8162
Suarez-Calvet, Xavier|||0000-0002-5314-6607
Jiménez Mallebrera, Cecilia|||0000-0001-8203-7103
Nascimento, Andrés
Llauger, Jaume|||0000-0002-3744-3257
Nuñez Peralta, Claudia Alejandra|||0000-0002-3235-0799
Montesinos, Paula|||0000-0001-6944-7730
Alonso Pérez, Jorge|||0000-0001-8866-5186
Gallardo, Eduard|||0000-0002-3942-3436
Illa, Isabel|||0000-0002-2186-2684
Diaz-Manera, Jordi|||0000-0003-2941-7988
author_role author
author2 Fernández Simón, Esther|||0000-0003-4804-6553
Natera-de Benito, Daniel|||0000-0001-7764-2085
Ortez González, Carlos Ignacio|||0000-0001-8187-8103
García, Carme
Montiel Morillo, Elena
Belmonte Jimeno, Izaskun|||0000-0003-0930-6586
Pedrosa Hernández, Irene
Segovia, Sonia
Piñol-Jurado, Patricia|||0000-0002-2757-5758
Carrasco-Rozas, Ana|||0000-0003-2165-8162
Suarez-Calvet, Xavier|||0000-0002-5314-6607
Jiménez Mallebrera, Cecilia|||0000-0001-8203-7103
Nascimento, Andrés
Llauger, Jaume|||0000-0002-3744-3257
Nuñez Peralta, Claudia Alejandra|||0000-0002-3235-0799
Montesinos, Paula|||0000-0001-6944-7730
Alonso Pérez, Jorge|||0000-0001-8866-5186
Gallardo, Eduard|||0000-0002-3942-3436
Illa, Isabel|||0000-0002-2186-2684
Diaz-Manera, Jordi|||0000-0003-2941-7988
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv PDGF
MRI
Biomarker
Duchenne
Becker
Dystrophinopathy
topic PDGF
MRI
Biomarker
Duchenne
Becker
Dystrophinopathy
description Introduction: Duchenne (DMD) and Becker (BMD) muscular dystrophy are X-linked muscular disorders produced by mutations in the DMD gene which encodes the protein dystrophin. Both diseases are characterized by progressive involvement of skeletal, cardiac, and respiratory muscles. As new treatment strategies become available, reliable biomarkers and outcome measures that can monitor disease progression are needed for clinical trials. Methods: We collected clinical and functional data and blood samples from 19 DMD patients, 13 BMD patients, and 66 healthy controls (8 pediatric and 58 adult controls), and blood samples from 15 patients with dysferlinopathy (DYSF) and studied the serum concentration of 4 growth factors involved in the process of muscle fibrosis. We correlated the serum concentration of these growth factors with several muscle function tests, spirometry results and fat fraction identified by quantitative Dixon muscle MRI. Results: We found significant differences in the serum concentration of Platelet Derived Growth Factor-AA (PDGF-AA) between DMD patients and pediatric controls, in Connective Tissue Growth Factor (CTGF) between BMD patients and adult controls, and in and Transforming Growth Factor- β1 (TGF-β1) between BMD and DYSF patients. PDGF-AA showed a good correlation with several muscle function tests for both DMD and BMD patients and with thigh fat fraction in BMD patients. Moreover, PDGF-AA levels were increased in muscle biopsies of patients with DMD and BMD as was demonstrated by immunohistochemistry and Real-Time PCR studies. Conclusion: Our study suggests that PDGF-AA should be further investigated in a larger cohort of DMD and BMD patients because it might be a good biomarker candidate to monitor the progression of these diseases.
publishDate 2021
dc.date.none.fl_str_mv 2
2021-01-01
2021
2021-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/256414
https://dx.doi.org/urn:doi:10.3389/fneur.2021.659922
url https://ddd.uab.cat/record/256414
https://dx.doi.org/urn:doi:10.3389/fneur.2021.659922
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.relation.none.fl_str_mv Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 PI15/01822
Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI18/1525
Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI19/00122
Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 CD18/00195
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869419996223897600
score 15,300719